Aditya Kohli

Aditya Kohli is a seasoned executive in the biotechnology sector, currently serving as the Chief Business Officer and Co-Founder of HilleVax since December 2020, alongside roles as Board Director and COO. Kohli holds a Venture Partner position at Frazier Life Sciences since September 2016 and has co-founded several companies, including Phathom Pharmaceuticals, Passage Bio, Recida Therapeutics, and Scout Bio. Prior professional experience includes leadership roles at Scout Bio and Phathom Pharmaceuticals, as well as engagement management at McKinsey & Company. Aditya Kohli's academic credentials include PhDs in Bioengineering from both the University of California, San Francisco and the University of California, Berkeley, complemented by a combined Bachelor's and Master's degree from the Massachusetts Institute of Technology in the same field.